CDMOs
CDMOs
CDMO Leadership Shuffles: Impact on Biotech
📌 Explore the impact of leadership shuffles at CDMOs in the biotech industry 🌍🔬. Find out why stability matters!
Biogen’s CDMO Revenues Set to Plummet!
📢 Biogen, a global biotech company, anticipates a decline in CDMO revenues as its Denmark commitments conclude. 😔
Game-Changing Merger Propels Biovian and 3P Globally
🔎 CDMOs Biovian and 3P merge to expand globally, covering the entire biotech development process. 🌍💼🤝📈
Novo Holdings Invests $165bn in CDMO Catalent Fueling Biotech Growth
🔍 Novo Holdings buys CDMO Catalent for $16.5bn, aiming to support its expansion in the CDMO market. 🏢💼📈
Game-Changing Merger Creates European CDMO Powerhouse
🔍 Biovian and 3P Biopharmaceuticals merge to create 3PBIOVIAN, a European CDMO offering end-to-end services. 🌍👥🔬🧫🧬💪
Revolutionary Startup Aims to Transform Cell and Gene Therapies
📰 Frustration with CDMOs fuels ambition for advanced therapy startup GDMC, offering end-to-end solutions for cell and gene therapies. 💡💪🌱🧬
Celltrion’s Game-Changing 5-Year Partnership Boosts Biotech
📢 Celltrion taps Prestige Bio in a 5-year CDMO deal, expanding its capabilities and strengthening its global position. 💼🌐💪📈
Pluri Revolutionizes Cell Therapy with Expanded CDMO Services
🌟 Pluri, a cell therapy pioneer, ventures into the CDMO space, offering end-to-end services for biotech development. 🚀
Astellas’ Gastric Cancer Treatment Rejected by FDA Blames CDMO
📢 Astellas' gastric cancer antibody rejected by FDA due to CDMO issues. Setback for treatment, importance of reliable CDMO highlighted. 😞🔍🏭📉💡
Supercharge Vaccine Development with Automation and Collaboration
🧪 Recombinant protein vaccines are safe, effective, and easy to store, making them a leading human vaccine technology. ⏰ Shortening the time from vaccine discovery to commercialization is crucial for better pandemic preparedness. 🤖 Automation and digitalization can speed up vaccine development. 👥 Collaboration and open access platforms can facilitate knowledge sharing and ensure global access to vaccines. 💪 Scalable biotech manufacturing facilities with modular and flexible technologies are essential for large-scale production. 🏭 CDMOs have become crucial in responding to vaccine production demands. 🌍 Ensuring stable supply chains and timely regulatory certifications is necessary for CDMOs.
